Off-Label Underdosing or Overdosing of Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
Background: Several studies have investigated the role of off-label non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF). We aimed to compare the effectiveness and safety outcomes between off-label underdose or overdose vs. on-label dose of NOACs in AF patie...
Main Authors: | Xiaojuan Wu, Linyan Hu, Jinjin Liu, Qiuping Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.724301/full |
Similar Items
-
Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
by: Nan-Nan Shen, et al.
Published: (2021-05-01) -
Association of Direct Oral Anticoagulants vs. Vitamin K Antagonists With Fractures in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
by: Xiaojuan Wu, et al.
Published: (2021-07-01) -
New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01) -
Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01) -
The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
by: Jan Beyer-Westendorf, et al.
Published: (2021-07-01)